Completion of treatment is key to tuberculosis control. Using national surveillance data we assessed factors associated with tuberculosis patients being lost to follow-up before completing treatment ('lost'). Patients reported in England, Wales and Northern Ireland between 2001 and 2007 who were lost 12 months after beginning treatment were compared to those who completed, or were still on treatment, using univariable and multivariable logistic regression. Of 41 120 patients, men [adjusted odds ratio (aOR) 1·29; 95% confidence interval (CI) 1·23-1·35], 15- to 44-year-olds (P<0·001), and patients with pulmonary sputum smear-positive disease (aOR 1·25, 95% CI 1·12-1·45) were at higher risk of being lost. Those recently arrived in the UK were ...
Background: Despite the available treatment options, pulmonary tuberculosis (TB) remains a leading c...
<div><p>Background</p><p>The treatment success rate of pulmonary tuberculosis (PTB) patients aged 64...
BACKGROUND: In 1998, the World Health Organization (WHO) and the International Union Against Tubercu...
OBJECTIVE: To assess the magnitude of loss to follow-up in smear- or culture-positive tuberculosis p...
Department of Pneumophthisiology, Nicolae Testemitsanu State University of Medicine and Pharmacy, Ch...
Background: The highest rate of patients with the low disease outcome is represented by the lost to ...
Objective To assess the magnitude of loss to follow-up in smear- or culture-positive tuberculosis...
Objective To identify factors associated with loss to follow-up in Tuberculosis (TB) treatment, incl...
In studies evaluating methods for diagnosing tuberculosis (TB), follow-up to verify the presence or ...
Background: Pretreatment loss to follow-up (PTLFU) is a barrier to tuberculosis (TB) control in Indi...
In studies evaluating methods for diagnosing tuberculosis (TB), follow-up to verify the presence or ...
In studies evaluating methods for diagnosing tuberculosis (TB), follow-up to verify the presence or ...
Sabah is a high tuberculosis (TB) burden area with incidence rate of 120 â 138 per 100,000 populatio...
Abstract Background Drug-resistant tuberculosis (DR-TB) is the barrier for global TB elimination eff...
Multidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted e...
Background: Despite the available treatment options, pulmonary tuberculosis (TB) remains a leading c...
<div><p>Background</p><p>The treatment success rate of pulmonary tuberculosis (PTB) patients aged 64...
BACKGROUND: In 1998, the World Health Organization (WHO) and the International Union Against Tubercu...
OBJECTIVE: To assess the magnitude of loss to follow-up in smear- or culture-positive tuberculosis p...
Department of Pneumophthisiology, Nicolae Testemitsanu State University of Medicine and Pharmacy, Ch...
Background: The highest rate of patients with the low disease outcome is represented by the lost to ...
Objective To assess the magnitude of loss to follow-up in smear- or culture-positive tuberculosis...
Objective To identify factors associated with loss to follow-up in Tuberculosis (TB) treatment, incl...
In studies evaluating methods for diagnosing tuberculosis (TB), follow-up to verify the presence or ...
Background: Pretreatment loss to follow-up (PTLFU) is a barrier to tuberculosis (TB) control in Indi...
In studies evaluating methods for diagnosing tuberculosis (TB), follow-up to verify the presence or ...
In studies evaluating methods for diagnosing tuberculosis (TB), follow-up to verify the presence or ...
Sabah is a high tuberculosis (TB) burden area with incidence rate of 120 â 138 per 100,000 populatio...
Abstract Background Drug-resistant tuberculosis (DR-TB) is the barrier for global TB elimination eff...
Multidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted e...
Background: Despite the available treatment options, pulmonary tuberculosis (TB) remains a leading c...
<div><p>Background</p><p>The treatment success rate of pulmonary tuberculosis (PTB) patients aged 64...
BACKGROUND: In 1998, the World Health Organization (WHO) and the International Union Against Tubercu...